A detailed history of Geode Capital Management, LLC transactions in Alector, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,755,585 shares of ALEC stock, worth $9.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,755,585
Previous 1,575,770 11.41%
Holding current value
$9.9 Million
Previous $9.49 Million 15.98%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$4.19 - $6.23 $753,424 - $1.12 Million
179,815 Added 11.41%
1,755,585 $7.97 Million
Q1 2024

May 13, 2024

BUY
$5.69 - $8.08 $1.1 Million - $1.57 Million
193,984 Added 14.04%
1,575,770 $9.49 Million
Q4 2023

Feb 13, 2024

BUY
$3.77 - $8.39 $296,732 - $660,368
78,709 Added 6.04%
1,381,786 $11 Million
Q3 2023

Nov 13, 2023

BUY
$5.2 - $8.77 $69,446 - $117,123
13,355 Added 1.04%
1,303,077 $8.44 Million
Q2 2023

Aug 11, 2023

BUY
$5.86 - $7.93 $416,048 - $563,014
70,998 Added 5.83%
1,289,722 $7.75 Million
Q1 2023

May 15, 2023

BUY
$5.85 - $9.84 $154,644 - $260,120
26,435 Added 2.22%
1,218,724 $7.54 Million
Q4 2022

Feb 13, 2023

BUY
$6.88 - $9.55 $507,475 - $704,417
73,761 Added 6.59%
1,192,289 $11 Million
Q3 2022

Nov 14, 2022

BUY
$8.19 - $13.2 $200,417 - $323,017
24,471 Added 2.24%
1,118,528 $10.6 Million
Q2 2022

Aug 12, 2022

BUY
$7.65 - $14.24 $135,925 - $253,016
17,768 Added 1.65%
1,094,057 $11.1 Million
Q1 2022

May 13, 2022

BUY
$13.02 - $20.78 $189,154 - $301,891
14,528 Added 1.37%
1,076,289 $15.3 Million
Q4 2021

Feb 11, 2022

BUY
$19.35 - $25.54 $1.2 Million - $1.58 Million
61,993 Added 6.2%
1,061,761 $21.9 Million
Q3 2021

Nov 12, 2021

BUY
$21.65 - $39.49 $414,835 - $756,667
19,161 Added 1.95%
999,768 $22.8 Million
Q2 2021

Aug 13, 2021

BUY
$15.5 - $22.48 $2.04 Million - $2.96 Million
131,612 Added 15.5%
980,607 $20.4 Million
Q1 2021

May 12, 2021

BUY
$14.84 - $22.23 $1.06 Million - $1.59 Million
71,647 Added 9.22%
848,995 $17.1 Million
Q4 2020

Feb 12, 2021

BUY
$9.4 - $16.7 $359,662 - $638,975
38,262 Added 5.18%
777,348 $11.8 Million
Q3 2020

Nov 13, 2020

BUY
$10.54 - $24.96 $919,425 - $2.18 Million
87,232 Added 13.38%
739,086 $7.79 Million
Q2 2020

Aug 13, 2020

BUY
$21.87 - $33.11 $2.16 Million - $3.27 Million
98,830 Added 17.87%
651,854 $15.9 Million
Q1 2020

May 14, 2020

BUY
$16.25 - $35.28 $2.37 Million - $5.14 Million
145,668 Added 35.76%
553,024 $13.3 Million
Q4 2019

Feb 13, 2020

BUY
$14.17 - $20.3 $497,579 - $712,834
35,115 Added 9.43%
407,356 $7.02 Million
Q3 2019

Nov 12, 2019

BUY
$14.42 - $22.2 $3.47 Million - $5.34 Million
240,575 Added 182.72%
372,241 $5.37 Million
Q2 2019

Aug 14, 2019

SELL
$16.26 - $26.42 $7,934 - $12,892
-488 Reduced 0.37%
131,666 $2.5 Million
Q1 2019

May 14, 2019

BUY
$15.97 - $22.5 $2.11 Million - $2.97 Million
132,154 New
132,154 $2.47 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $466M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.